kabutan

TAUNS Laboratories,Inc.(197A) Summary

197A
TSE Standard
TAUNS Laboratories,Inc.
493
JPY
+6
(+1.23%)
Apr 28, 3:30 pm JST
3.09
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
495
Apr 28, 9:41 pm JST
Summary Chart Historical News Financial Result
PER
9.2
PBR
3.02
Yield
5.68%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
488 JPY 3.06 USD
Previous Close Apr 27
487 JPY 3.05 USD
High Apr 28, 3:11 pm
493 JPY 3.09 USD
Low Apr 28, 9:00 am
487 JPY 3.05 USD
Volume
245,400
Trading Value
0.12B JPY 0.76M USD
VWAP
490.26 JPY 3.08 USD
Minimum Trading Value
49,300 JPY 309 USD
Market Cap
0.05T JPY 0.33B USD
Number of Trades
341
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly High
1-Year Average
523
1-Year High Jul 15, 2025
1,982
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 313,800 1,972,000 6.28
Apr 17, 2026 311,700 1,943,200 6.23
Apr 10, 2026 340,300 2,132,600 6.27
Apr 3, 2026 234,400 1,838,600 7.84
Mar 27, 2026 109,800 1,797,200 16.37
Company Profile
TAUNS Laboratories, Inc. specializes in the development and manufacture of in vitro diagnostic medical devices and research reagents.
Sector
Pharmaceuticals
TAUNS Laboratories, Inc. focuses on the development and manufacture of in vitro diagnostic medical devices and research reagents as its core business, primarily offering antigen test kits for infectious disease clinical testing. By utilizing the immunochromatographic method, the company enables rapid diagnosis without the need for specialized equipment. Key features of their products include the common use of specimen extraction solution and high visibility black lines achieved through their proprietary "platinum-gold colloid" nanotechnology. The company provides its products to domestic and international medical institutions, international organizations, research institutes, and biotech ventures. Their main product line includes test kits for influenza, novel coronavirus, adenovirus, and RSV, among others.